Nilandron

— THERAPEUTIC CATEGORIES —
  • Prostate and other male cancers

Nilandron Generic Name & Formulations

General Description

Nilutamide 150mg; tabs.

Pharmacological Class

Antiandrogen.

How Supplied

Tabs—30

Nilandron Indications

Indications

Metastatic prostate cancer (Stage D2), as an adjunct to surgical castration.

Nilandron Dosage and Administration

Adult

300mg once daily for 30 days then 150mg once daily, starting day of or day after surgical castration.

Children

Not applicable.

Nilandron Contraindications

Contraindications

Severe hepatic impairment or respiratory insufficiency.

Nilandron Boxed Warnings

Boxed Warning

Interstitial pneumonitis.

Nilandron Warnings/Precautions

Warnings/Precautions

Obtain baseline liver and pulmonary function tests, routine chest X-ray. Monitor for interstitial pneumonitis; discontinue if symptoms occur. Monitor liver function for first 4 months then periodically; discontinue if ALT > 2xULN or jaundice occurs. May discolor urine or sclera. Pregnancy (not for use in women). Nursing mothers.

Nilandron Pharmacokinetics

See Literature

Nilandron Interactions

Interactions

Monitor drugs metabolized by CYP450 (eg, Vit. K antagonists, theophylline, phenytoin); may need to adjust dose. May cause alcohol intolerance.

Nilandron Adverse Reactions

Adverse Reactions

Hot flushes, impaired night vision, GI upset, increased liver enzymes, constipation, dizziness, abnormal vision, hypertension, hepatitis, interstitial pneumonitis.

Nilandron Clinical Trials

See Literature

Nilandron Note

Not Applicable

Nilandron Patient Counseling

See Literature